R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
Darmstadt, June 7, 2022 – R-Biopharm AG, a leading German biotechnology company operating on a global scale, announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment. The company is thereby unlocking new market segments in clinical diagnostics and continuing on its path of steady internationalization. “The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio,” states Christian Dreher, CEO of R-Biopharm. “The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics.”
Upon its establishment in 2006, the Australian company introduced its patented Multiplex Tandem PCR (MT-PCR) on the market. The current technology allows the simultaneous detection of up to 24 pathogens or resistance genes from a single sample, thus shortening the lengthy test procedure in human and animal diagnostics as well as environmental, agricultural, and food analysis. The analysis platform is used in laboratories and hospitals throughout the world for detecting a broad range of diseases.
AusDiagnostics CEO Scott Gilroy said that the transaction marked an exciting new chapter for the company: “Both AusDiagnostics and R-Biopharm AG share the same commitment to innovation in the biotechnology space. This acquisition strengthens AusDiagnostics and will accelerate our global presence. We’ve experienced tremendous, industry-leading growth over the past two years, which has been underpinned by our broad suite of innovative products, talented team, and incredible, loyal customers. Joining the R-Biopharm group will allow us to further build on this and continue to deliver exceptional products and service for our Australian and international customers.”
AusDiagnostics currently has 92 employees with offices in New Zealand, the USA, and Great Britain. Its production facilities in Australia and Great Britain supply a steadily growing network of more than 25 distributors and partners around the world – from which R-Biopharm expects further synergy effects for production as well as international service and support in its clinical diagnostics line.
About R-Biopharm
R-Biopharm AG, located in Darmstadt, is one of Germany’s leading biotechnology companies. It considers itself as a pioneer for health and quality of life. The company´s aspiration is to provide the highest possible precision, safety, clarity and certainty with excellent products and solutions – in prevention, therapy and healing. Research and development at R-Biopharm has developed agile processes in order to take on new challenges to accompany a steadily growing world population into a new health era with sustainable solutions.
As an internationally recognized leader, R-Biopharm stands for the development of excellent technologies, products and solutions in the fields of Clinical Diagnostics, Nutrition Care and Food and Feed Analytics. R-Biopharm is the global market leader for test systems in the field of allergen analysis. The biotechnology company is known for its products that are of high importance for human health. To this end, it unites development, production and sales under one roof and is successfully represented in more than 120 countries worldwide – through 28 subsidiaries and 120 distributors. Founded in 1988, the family-run company employs a total of around 1,300 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the “Sustainability Award” for sustainable and profitable growth. R-Biopharm is cultivating a value-oriented corporate culture and management and is family-run in the second generation. The Chairman of the Board of Directors is Christian Dreher.
Press contact:
Simone Feiler
Head of Corporate Brand Communication
https://r-biopharm.com/
https://r-biopharm.com/news-press/download-gallery/
R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt, Germany
Tel.: +49 61 51 - 81 02-538
Mobile: +49 160 - 55 273 60
Fax: +49 61 51 - 81 02-40
Email: s.feiler@r-biopharm.de
Bilder
Om news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
MT Raceteam entering Ligier European Series with 16 year old Marcus Terkildsen / attractive partnerships and high visibility available18.12.2025 14:00:58 CET | Press release
MT Raceteam is proud to announce its 2026 entry into the prestigious Ligier European Series, where the team will compete in a state-of-the-art Ligier JS2 R supplied by 23 Events Racing. This marks an important milestone for both the team and sixteen-year-old Danish driver Marcus Terkildsen as they step into one of Europe’s most competitive championships.
NTT DATA acquires The Cloud People to expand ServiceNow expertise and strengthen global reach18.12.2025 12:00:00 CET | Press release
(Bielefeld, Germany/Oslo, Norway) — NTT DATA announces the acquisition of The Cloud People Group AS, one of the largest pure-play ServiceNow partners in Europe. Founded in 2019, The Cloud People is headquartered in Oslo, Norway, with offices across northern Europe, the USA and Brazil, and will become part of NTT DATA Business Solutions, a business unit of NTT DATA. As a leading provider of ServiceNow solutions for medium and large enterprises, The Cloud People offer a focused value proposition covering the entire ServiceNow platform. The company delivers services across multiple workflows including IT service management, incident, problem and change management, automation of routine tasks, resource planning, onboarding and offboarding of employees, as well as customer service and security operations. The acquisition of The Cloud People will add 130 active customers to NTT DATA Business Solutions’ portfolio. The Cloud People is at the forefront of ServiceNow’s AI evolution with its dedi
fulfillmenttools Delivers Global Order Management Solution for DEICHMANN18.12.2025 11:09:09 CET | Press release
fulfillmenttools will support DEICHMANN in streamlining its order processing across different channels. The platform connects and manages the retailer’s inventory and order management across several countries, online shops, physical stores, and marketplaces. Partnering with Europe’s leading footwear retailer highlights fulfillmenttools’ strong position in Order Management and demonstrates the solution’s adaptability for international commerce.
ZEISS concludes fiscal year 2024/25 with solid growth18.12.2025 11:00:00 CET | Press release
Revenue totaled almost 12 billion euros, with EBIT at 1.552 billion euros. The segments once again presented a mixed picture. Targeted resilience measures and investments in innovative strength are the key to the future.
Innovative Support AI “Neo” Launches in the New Customer App from PLAN-B NET ZERO12.12.2025 09:00:00 CET | Press release
Zug/Berlin, December 12, 2025 – With “Neo”, PLAN-B NET ZERO is introducing a new generation of digital customer support: an AI that answers energy-related questions in real time, resolves requests automatically and is available around the clock. Faster, more precise and more personal than traditional service models.
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom